SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a significant analyst upgrade and intense community anticipation ahead of the upcoming AAD conference in Denver, where long-term Phase 3 data for sonelokimab is expected to be presented. Investors are closely monitoring potential acquisition interest from major pharmaceutical players while debating whether clinical outcomes will confirm the therapy as best-in-class.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant market interest as investors closely monitor reports of a major spodumene supply deficit and rising lithium futures. While bullish community sentiment is fueled by expectations of strong 2026 growth and potential production capacity increases, the stock remains a battlefield between retail investors anticipating a breakout and short sellers targeting concerns over operational timelines and liquidity.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors weigh an upcoming earnings report against significant concerns regarding execution gaps in China, intensifying domestic competition, and a persistent multi-month downtrend. The community is sharply divided, with bulls pointing to historical support levels and insider buying by key executives as a sign of a potential turnaround, while bears highlight consistent technical weakness and structural risks.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors closely monitor the development of Project Matador and anticipate a potential tenant announcement, following reports of a substantial equipment financing facility and strategic partnerships. The community remains actively divided, with many debating the company's timeline for operational capacity and power grid integration, while others highlight the massive short interest and potential for a significant upside breakout once a definitive data center tenant is secured.

Roma Green Finance Ltd. is a holding company, which engages in the provision of environmental, social and governance, sustainability, and climate change related advisory services through its subsidiaries. Its services include corporate and risk advisory, sustainability strategy services, climate risk advisory, ESG reporting services, and sustainable finance. The company was founded in 2018 and is headquartered in Hong Kong.

Roma Green Finance Ltd - Ordinary Shares - Class A

Roma Green Finance Ltd

Roma Green Finance is seeing increased attention as investors track its recent momentum, with the community actively debating whether the stock is primed for a breakout or remains a volatile candidate for a pump-and-dump. Traders are closely monitoring key support levels and volume patterns, frequently referencing its history of sharp price swings and the speculative potential often associated with small-cap stocks in this sector.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing increased attention as investors closely monitor its pipeline of thyroid eye disease treatments, particularly following a series of analyst updates and the company's progress toward key clinical milestones. Community discussion remains centered on the potential for its therapies to offer a competitive edge in the market, while shareholders navigate broader volatility in the biotech sector.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors weigh the impact of newly launched spot ETFs and heightened institutional interest against broader crypto market volatility. Community members are actively debating the token's long-term utility in global payments and speculating on potential price action amid evolving regulatory clarity.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors digest the company's transition to a fully integrated domestic magnet producer, highlighted by a major new partnership with the Department of War and milestone prepayments from Apple. The community remains focused on the upcoming earnings report and potential supply chain shifts, with bullish sentiment driven by the firm's central role in U.S. efforts to reduce reliance on foreign-sourced rare earth elements.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is trending following the announcement that its TETON-1 study for nebulized Tyvaso in idiopathic pulmonary fibrosis met its primary efficacy endpoint, sparking active debate among the community regarding its competitive position against other inhaled treatments and potential long-term growth prospects. Investors are closely monitoring the company's broader pipeline developments, including xenotransplantation and future partnerships, while weighing the impact of intensifying sector competition on the stock's long-term valuation.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Gold and Silver Corporation

Americas Gold and Silver is trending as investors monitor the company's recent acquisition of the Crescent Silver Mine and its strategic positioning in the domestic antimony market. Market participants are actively discussing the stock's high institutional ownership and potential for rapid growth as the company aims to quadruple silver production while benefiting from record-high precious metal prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Firefly Stock Jumps On Department Of Defense Partnership

Firefly Neuroscience, Inc. shares are trading higher Thursday after it announced a public-private partnership with the Department of Defense.read more...

<ul class="summary-bullets"><li>The collaboration is based on earlier studies conducted with the U.S. Naval Medical Center program.</li><li>The total economic impact of PTSD in the U.S. is estimated at $232.2 billion.</li><li>Firefly’s system provides objective neurological data to guide accurate diagnoses and customised treatment plans.</li></ul>Firefly Neuroscience Inc. (AIFF) announced on Thursday an agreement with the Department of War to deploy its artificial intelligence-driven EEG/ERP platform for evaluating and treating active-duty personnel and veterans affected by PTSD and traumatic brain injuries.The initiative focuses on using advanced brain-monitoring technology to address persistent challenges tied to military health.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/AIFF">Firefly Neuroscience stock</a> traded over 33% on Thursday morning.&nbsp;On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bearish’ territory the previous day amid ‘normal’ message volume levels.&nbsp;<h2 class="st-heading-2">Partnership With Defense Sector</h2>The effort builds on earlier research conducted with a U.S. Naval Medical Center program, laying the groundwork for broader adoption across military healthcare systems.Post-traumatic stress disorder and traumatic brain injuries remain among the most pressing issues facing the armed forces. The overall additional economic impact of PTSD in the U.S. is estimated at $232.2 billion, with roughly $42.7 billion linked specifically to service members and veterans.<h2 class="st-heading-2">Technology And Clinical Application</h2>Firefly’s platform, which has received clearance from the U.S. Food and Drug Administration (FDA), uses AI to analyze brainwave activity and deliver objective neurological insights. The system aims to assist clinicians in making more accurate diagnoses, tailoring treatment strategies, and tracking patient progress over time.&nbsp;<blockquote>“We believe that this ongoing strategic partnership positions us well to benefit from the significant and growing U.S. government investment in military brain health — with a validated, FDA-cleared platform.”-Greg Lipschitz, CEO, Firefly</blockquote>AIFF stock has gained over 90% year to date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/navn-stock-draws-cheer-after-strong-q4-bmo-sees-upside-to-share-price-dismisses-ai-concerns/cZ3rw6FRIjz">NAVN Stock Draws Cheer After Strong Q4 – BMO Sees 76% Upside To Share Price, Dismisses AI Concerns</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)

Why Did AIFF Stock Surge Over 33% Today?

The company will deploy its AI-powered EEG/ERP system to assess and treat brain injuries in service members and veterans.

Equity

The company will deploy its AI-powered EEG/ERP system to assess and treat brain injuries in service members and veterans.


Best Artificial Intelligence Stocks To Follow Now - March 15th

SentinelOne, Tempus AI, Firefly Neuroscience, SoundHound AI, and Upstart are the five Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial...

Artificial Intelligence Stocks Worth Watching - March 14th

SentinelOne, Tempus AI, and Firefly Neuroscience are the three Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial intelligence stocks are shares...

Why Firefly Neuroscience Stock Is Soaring Today

Firefly Neuroscience shares are trading higher Friday after it advanced research using its Evoke System to help distinguish ADHD subtypes.read more...

Top Artificial Intelligence Stocks To Watch Now - March 13th

Tempus AI, Firefly Neuroscience, SentinelOne, BigBear.ai, and Hut 8 are the five Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial intelligence...

AIFF Stock Surged Nearly 50% Today – Here’s Everything To Know About Its AI-Powered Solution To Identify ADHD Subtypes

The company said its technology analyzes EEG brain scans to identify patterns that could distinguish different ADHD subtypes.

Firefly Neuroscience Stock Surges 43% Over Advancement In Differential Diagnosis Of ADHD

(RTTNews) - Shares of Firefly Neuroscience, Inc. (AIFF) are surging roughly 43 percent on Friday morning trading following the announcement of discovery of new brain wave biomarkers for differential...

AI, Diagnostics and Next-Gen Materials Drive Innovation Push Across Emerging Growth Stocks

A wave of developments across emerging technology and life sciences companies underscores how artificial intelligence, advanced diagnostics, and next-generation biomaterials are converging to reshape several high-growth sectors. $ISPC, $AIFF, $KBLB, $BIAF, $ACXP, $KIDZ

What's Going On With Firefly Neuroscience Stock On Friday?

Firefly Neuroscience stock climbs after a major expansion in brain scan partnerships and rapid growth in its EEG data network.read more...

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

Firefly Neuroscience Inc.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

AIFF
Firefly Neuroscience Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AIFF News

AIFFFirefly Neuroscience Inc.